BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15702160)

  • 1. [Could Vioxx have been recalled earlier?].
    Moan A
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):323-4. PubMed ID: 15702160
    [No Abstract]   [Full Text] [Related]  

  • 2. Was Vioxx really that dangerous?
    Park A
    Time; 2005 Feb; 165(9):52. PubMed ID: 15765852
    [No Abstract]   [Full Text] [Related]  

  • 3. Merck withdraws Vioxx; FDA issues public health advisory.
    FDA Consum; 2004; 38(6):11. PubMed ID: 15675020
    [No Abstract]   [Full Text] [Related]  

  • 4. Balancing risks and benefits in pain medicine: wither Vioxx.
    Gallagher RM
    Pain Med; 2004 Dec; 5(4):329-30. PubMed ID: 15563316
    [No Abstract]   [Full Text] [Related]  

  • 5. The fallout from Vioxx.
    DeMaria AN
    J Am Coll Cardiol; 2004 Nov; 44(10):2080-1. PubMed ID: 15542295
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug pullout. Massive recall of Vioxx poses logistical problems.
    Becker C
    Mod Healthc; 2004 Oct; 34(42):17. PubMed ID: 15552189
    [No Abstract]   [Full Text] [Related]  

  • 7. What is a 'safe' drug?
    Healy B
    US News World Rep; 2004 Dec; 137(21):37. PubMed ID: 15636504
    [No Abstract]   [Full Text] [Related]  

  • 8. Causation, Vioxx, and legal issues.
    Green MD
    Science; 2005 Nov; 310(5750):973. PubMed ID: 16284163
    [No Abstract]   [Full Text] [Related]  

  • 9. The Vioxx debacle.
    Alpert JS
    Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713
    [No Abstract]   [Full Text] [Related]  

  • 10. Will Merck survive Vioxx?
    Simons J; Stipp D
    Fortune; 2004 Nov; 150(9):90-2, 94, 96-7 passim. PubMed ID: 15543824
    [No Abstract]   [Full Text] [Related]  

  • 11. The Vioxx debacle revisited.
    Mohapatra PR; Janmeja AK
    Am J Med; 2005 Sep; 118(9):1058. PubMed ID: 16164909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Slime fight in the lay media. Were the Vioxx fatal cases kept secret?].
    Zierenberg O
    MMW Fortschr Med; 2004 Oct; 146(43):60. PubMed ID: 15559526
    [No Abstract]   [Full Text] [Related]  

  • 13. COX-2 inhibitors--first, do no harm.
    Weatherall M; Aldington S; Shirtcliffe P; Caldwell B; Beasley R
    N Z Med J; 2005 Mar; 118(1211):U1359. PubMed ID: 15778758
    [No Abstract]   [Full Text] [Related]  

  • 14. Vioxx award good news for Canadian lawsuits.
    Eggertson L
    CMAJ; 2005 Sep; 173(7):744. PubMed ID: 16186576
    [No Abstract]   [Full Text] [Related]  

  • 15. The law. Vioxx verdict: too little or too much science?
    Lawler A
    Science; 2005 Sep; 309(5740):1481. PubMed ID: 16141043
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors.
    Couzin J
    Science; 2004 Oct; 306(5695):384-5. PubMed ID: 15486258
    [No Abstract]   [Full Text] [Related]  

  • 17. Ten lessons to be learned from the withdrawal of Vioxx (rofecoxib).
    Carné X; Cruz N
    Eur J Epidemiol; 2005; 20(2):127-9. PubMed ID: 15792277
    [No Abstract]   [Full Text] [Related]  

  • 18. Merck VIOXX "warning" is questioned.
    Allen TS; Henderson JH
    Tex Med; 2005 May; 101(5):5-6. PubMed ID: 15948521
    [No Abstract]   [Full Text] [Related]  

  • 19. [The rise and fall of Vioxx: society, values and their choice].
    Caspi D
    Harefuah; 2004 Nov; 143(11):770-1. PubMed ID: 15603261
    [No Abstract]   [Full Text] [Related]  

  • 20. COX-2 inhibitor use after Vioxx: careful balance or end of the rope?
    Fendrick AM
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):740-1. PubMed ID: 15623263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.